Orphan Drugs Summit 2011

The Orphan Drugs Summit 2011 is a high level platform for experience sharing amongst Orphan Drugs professionals. Our business approach is to offer a program which contains a wide range of well-designed topics, with key stakeholders at our speaking panels and extensive networking and benchmarking activities as means to enhance business knowledge.

Our participants’ superior customer experience is at the heart the Pharma Division, which has conducted an extensive research, covering the Nordics, European member states and the US environments, to produce a quality agenda which truly reflects the current challenges faced by the orphan drugs community.

Orphan Drugs and Rare Diseases Stakeholders Attending:

• A Pharmaceutical companies in the fields of oncology, haemophilia, genetic therapies, paediatrics and other rare diseases fields.
• A Biotech organisations involved with orphan drugs
• A Patient Organisations and Patient Access Institutions
• A European and Member States Regulatory Bodies
• A Payers & Reimbursement Authorities, HTAs
• A Academics, Research Centres, Public Sector entities and Hospitals

Medicon Valley members are eligible for registration and presentation discounts. Please book with the Registration Code "CCMM" in the online registration form and save EUR 500 per person.

The agenda can be found at: www.OrphanDrugsSummit.com/agenda

For further information and for online registration, please visit:

www.OrphanDrugsSummit.com